𝔖 Bobbio Scriptorium
✦   LIBER   ✦

First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: Cost-minimization analysis

✍ Scribed by Nerich, V.; Chelly, J.; Montcuquet, P.; Chaigneau, L.; Villanueva, C.; Fiteni, F.; Meneveau, N.; Perrin, S.; Voidey, A.; Monnot, T.; Pivot, X.; Limat, S.

Book ID
121359321
Publisher
SAGE Publications
Year
2013
Tongue
English
Weight
187 KB
Volume
20
Category
Article
ISSN
1078-1552

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Trastuzumab plus vinorelbine or taxane c
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study
✍ Harold J. Burstein; Aparna Keshaviah; Ari D. Baron; Ronald D. Hart; Rosemary Lam πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 157 KB

## Abstract ## BACKGROUND. The optimal trastuzumab‐based chemotherapy regimen for HER2‐overexpressing, metastatic breast cancer is not known. The __tr__astuzumab __a__nd __vi__norelbine __o__r __ta__xane (TRAVIOTA) study was a prospective, multicenter, randomized trial that was designed to compare